The Hunter's Dawn: Tracking Gap Prey in Bullish Territory
By Laegolin Swiftbow, Ancient Elven Gap Trader
The morning mist clears over our hunting grounds, revealing a landscape dominated by bullish winds with 5 indexes rising and only 1 falling. This creates ideal conditions for stalking gap-down prey while remaining wary of gap-up quarry that may have the momentum wind at their backs.
MAUREL ET PROM (MAU.PA): The Justified Leaper (+4.00%)
This French oil explorer has bounded upward €0.21 to €5.33, and the scent trail is clear—a massive $496M asset sale to Heirs Energies. With 170% of normal volume already tracking through our territory, this gap appears well-justified by fundamental news. However, the 5-day order flow shows SELLERS_INCREASING with a -0.0633 slope, suggesting institutional hunters have been reducing positions recently. The gap sits above the daily pivot at €5.10, but at current levels near €5.33, we're hunting in thin air above resistance at R2 €5.18. The prey may pause for breath at the 38.2% Fibonacci pullback at €5.09 before deciding its next move. Given the strong news catalyst, this quarry deserves patient observation rather than immediate pursuit.
TRAINLINE (TRN.LO): The Overextended Runner (+5.07%)
This UK rail booking platform has sprinted from €220.80 to €232.00, but the news trail is weak—merely industry speculation about Great British Railways. A 5% gap on routine regulatory chatter? My elven instincts detect an unjustified leap. The order flow trend shows SELLERS_INCREASING (-0.0160), and volume remains suspiciously light. Trading well above the pivot at €220.87 and even above R2 at €224.27, this prey has ventured far from safe territory. The 61.8% Fibonacci pullback at €220.50 aligns beautifully with yesterday's close, suggesting a natural return path. With bullish indexes supporting any bounce, a fade here offers excellent risk-reward as we hunt this gap back toward fair value.
OXFORD BIOMEDICA (OXB.LO): The Wounded Stag (-4.97%)
A -€31 gap down to €593 on this biotech, with no significant news to justify such a stumble. This wounded creature has fallen below the daily pivot at €622.33, presenting classic gap-down fade territory. The 5-day ATR of €28.84 suggests normal daily movement around 4.6%, making this gap at the edge of normal volatility but still potentially overdone. With SELLERS_INCREASING order flow (-0.0959 slope), recent institutional activity has been negative, yet the absence of fundamental news suggests this may be technical selling rather than informed disposal. The bullish index environment provides favorable winds for a recovery hunt toward the 50% Fibonacci bounce target at €621.50.
APPLIED NUTRITION (APN.LO): The Elusive Phantom (+5.73%)
This nutrition company has gapped up €14 to €258, but the volume whispers tell a concerning tale—virtually no liquidity with just 1,131 shares traded versus a 642,230 daily average. Hunting phantoms in illiquid markets rarely ends well for gap traders. Despite an attractive 5% gap, the lack of volume makes this prey too dangerous to stalk.
HYLORIS PHARMACEUTICALS (HYL.BR): The Energetic Climber (+5.45%)
A €0.34 gap higher to €6.58 on this Belgian pharma, with BUYERS_INCREASING order flow (+0.4031 slope) showing recent institutional accumulation. However, with no news catalyst and a 5% ATR suggesting high daily volatility, this appears to be momentum rather than fundamental movement. The gap deserves monitoring as it develops.
The Hunt Summary:
In today's bullish environment, gap-down fades align with index winds while gap-ups require exceptional justification. Oxford Biomedica presents our clearest fade opportunity, while Trainline offers a higher-conviction hunt despite the challenging gap-up direction.